As cases of monkeypox rise in the US, unnamed sources are indicating the government will push for transdermal injection for Jyneos, the monkeypox vaccine produced by Bavarian Nordic. The scale of the outbreak, which resulted in a declaration of a national health emergency just last week, combined with the small supply of the vaccine has officials looking into resource-saving measures. The procedure requires just one-fifth the dose of the standard subcutaneous injection route, but requires specialized training to perform.
According to William Schaffner, a professor of infectious disease at Vanderbilt, “The best example we have of doing this in a widespread fashion previously is with the, rather now old-fashioned, TB tuberculosis skin tests. There are still many nurses working, and some retired, who were expert at doing this. It’s a bit of an art form. The average nurse probably in their training may never have given an intradermal inoculation or had only very brief exposure.”
To read more, click here.
(Source: Endpoints News, August 9th, 2022)